136 related articles for article (PubMed ID: 21476455)
21. Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: a retrospective analysis.
Gunjur A; Lau E; Taouk Y; Ryan G
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):603-10. PubMed ID: 22141608
[TBL] [Abstract][Full Text] [Related]
22. Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma - three case reports - .
Sakamoto N; Ishikawa E; Yamamoto T; Satomi K; Nakai K; Sato M; Enomoto T; Morishita Y; Takano S; Ohno T; Tsuboi K; Matsumura A
Neurol Med Chir (Tokyo); 2011; 51(4):319-25. PubMed ID: 21515959
[TBL] [Abstract][Full Text] [Related]
23. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.
Turner SG; Gergel T; Wu H; Lacroix M; Toms SA
World J Surg Oncol; 2014 May; 12():162. PubMed ID: 24884522
[TBL] [Abstract][Full Text] [Related]
24. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
25. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
[TBL] [Abstract][Full Text] [Related]
26. Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma.
Poelen J; Prick MJ; Jeuken JW; Wesseling P; Bernsen HJ
Acta Neurol Belg; 2009 Sep; 109(3):238-42. PubMed ID: 19902821
[TBL] [Abstract][Full Text] [Related]
27. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas.
Rhee DJ; Kong DS; Kim WS; Park KB; Lee JI; Suh YL; Song SY; Kim ST; Lim DH; Park K; Kim JH; Nam DH
Clin Neurol Neurosurg; 2009 Nov; 111(9):748-51. PubMed ID: 19716649
[TBL] [Abstract][Full Text] [Related]
29. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
[TBL] [Abstract][Full Text] [Related]
30. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.
Lee IH; Piert M; Gomez-Hassan D; Junck L; Rogers L; Hayman J; Ten Haken RK; Lawrence TS; Cao Y; Tsien C
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):479-85. PubMed ID: 18834673
[TBL] [Abstract][Full Text] [Related]
31. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.
Mangla R; Singh G; Ziegelitz D; Milano MT; Korones DN; Zhong J; Ekholm SE
Radiology; 2010 Aug; 256(2):575-84. PubMed ID: 20529987
[TBL] [Abstract][Full Text] [Related]
32. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
[TBL] [Abstract][Full Text] [Related]
33. Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value.
Yoo RE; Choi SH; Kim TM; Lee SH; Park CK; Park SH; Kim IH; Yun TJ; Kim JH; Sohn CH
AJNR Am J Neuroradiol; 2015 Oct; 36(10):1846-52. PubMed ID: 26294653
[TBL] [Abstract][Full Text] [Related]
34. Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide.
Tseng HM; Kuo LT; Lien HC; Liu KL; Liu MT; Huang CY
Anticancer Drugs; 2010 Nov; 21(10):963-7. PubMed ID: 20838208
[TBL] [Abstract][Full Text] [Related]
35. MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.
Kim BR; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
PLoS One; 2016; 11(11):e0166096. PubMed ID: 27835666
[TBL] [Abstract][Full Text] [Related]
36. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
Gorlia T; van den Bent MJ; Hegi ME; Mirimanoff RO; Weller M; Cairncross JG; Eisenhauer E; Belanger K; Brandes AA; Allgeier A; Lacombe D; Stupp R
Lancet Oncol; 2008 Jan; 9(1):29-38. PubMed ID: 18082451
[TBL] [Abstract][Full Text] [Related]
37. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
[TBL] [Abstract][Full Text] [Related]
38. Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.
Dobelbower MC; Burnett Iii OL; Nordal RA; Nabors LB; Markert JM; Hyatt MD; Fiveash JB
J Med Imaging Radiat Oncol; 2011 Feb; 55(1):77-81. PubMed ID: 21382192
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme.
De Sanctis V; Mazzarella G; Osti MF; Valeriani M; Alfó M; Salvati M; Banelli E; Tombolini V; Enrici RM
Anticancer Drugs; 2006 Sep; 17(8):969-75. PubMed ID: 16940807
[TBL] [Abstract][Full Text] [Related]
40. Potential usefulness of radiosensitizers in glioblastoma.
Harasaki Y; Waziri A
Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
